Primary briefing · Gazette
high impact 54778 · 7552 · 2026-06-04
Proposed Indigenous Knowledge Regulations: new licensing, benefit-sharing, and penalty regime published for comment
Comment closes
04 Aug 2026
Government Notice 7552 of 4 June 2026 publishes the first-ever proposed regulations under the Protection, Promotion, Development and Management of Indigenous Knowledge Act 6 of 2019. The regulations establish a comprehensive framework requiring any entity commercialising indigenous knowledge to obtain a formal licence (Form G), supported by proof of prior informed consent, a benefit-sharing agreement, and a community trustee reference. A registration system administered by NIKSO is created, with a R100 application fee and a 30-day certificate-issuance timeline. Annual subscription fees are prescribed: R5,000 for industry, R2,500 for researchers, R10,000 for patent offices, and R1,500 for civil society, communities, and practitioners. Accreditation of assessors and certification of practitioners, a dispute resolution committee with a 60-day resolution deadline, and recognition of prior learning norms are also introduced. Penalties for non-compliance reach up to R400,000 for individuals or 40% of annual turnover for juristic entities.
Who is affected
Biotechnology and bioprospecting companiesPharmaceutical companiesAgricultural and food-systems enterprisesResearch institutions and academia accessing indigenous knowledgePatent attorneys and IP practitionersTraditional medicine and indigenous health practitionersIndigenous communities and their trusteesEnvironmental management and biodiversity sectors What this means for practitioners
Assess whether current or planned activities involve the commercialisation or use of indigenous knowledge or biological resources that would trigger the licensing requirement.
Prepare and submit written comments or representations before the comment deadline of approximately 4 August 2026.
Review the prescribed fee schedule (annual subscriptions of R5,000–R10,000 depending on category) and penalty provisions (up to 40% of annual turnover for juristic entities) for budget and risk impact.
Evaluate existing benefit-sharing, material transfer, and non-disclosure agreements against the new Form G requirements.
Brief clients in biotech, pharma, agriculture, and research sectors on the proposed regime and the comment opportunity.